Page 7 - ஆரோக்கியம் பராமரிப்பு கஂப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sangui BioTech International Inc.: - Granulox(R) - Follow up 11.05.2021 / 11:05 Sangui BioTech: - Granulox(R) - Follow up Hamburg, May, 11 2021: With this letter we would like to briefly summarize the events since the acquisition of Sastomed GmbH by the Mölnlycke Health Care Group and point out the latest developments in the Granulox(R) wound spray. The acquisition of SastoMed GmbH by the Mölnlycke Health Care Group at the end of June 2018 was the starting point for an extensive integration and reorganization program with the target of increasing the market potential of the Granulox(R) wound spray. In addition to adapting the logistical processes, these measures also included legal changes. With the merger of Sastomed GmbH in 2020 with its parent company Mölnylcke Health Care GmbH, Mölnylcke Health Care GmbH is now the contractional licensee of Granulox(R). In addition, extensive and sometimes lengthy restructuring process was carried out in the sales area. The integration

Thomas striepeSastomed gmbHealth care gmbSangui biotech international incHealth careHealthcare groupSangui biotechSastomed gmbhHealth care gmbhBiotech internationalஆரோக்கியம் பராமரிப்பு க்ம்ப்ஆரோக்கியம் பராமரிப்புசுகாதாரம் குழுஆரோக்கியம் பராமரிப்பு கஂப்பயோடெக் சர்வதேச